Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35443108

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Apr 21
First author
Montesinos P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 Jul;19(7):427. doi: 10.1038/s41571-022-00644-y.
    note
    Source null
    related pmid
    35534622
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jun 30;386(26):2535-2536. doi: 10.1056/NEJMc2206489.
    note
    Source null
    related pmid
    35767448
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Jun 30;386(26):2536. doi: 10.1056/NEJMc2206489.
    note
    Source null
    related pmid
    35767449
    relationship
    Comment in

Authors and identifiers

  1. name
    Montesinos P
    type
    Author
  2. name
    Recher C
    type
    Author
  3. name
    Vives S
    type
    Author
  4. name
    Zarzycka E
    type
    Author
  5. name
    Wang J
    type
    Author
  6. name
    Bertani G
    type
    Author
  7. name
    Heuser M
    type
    Author
  8. name
    Calado RT
    type
    Author
  9. name
    Schuh AC
    type
    Author
  10. name
    Yeh SP
    type
    Author
  11. name
    Daigle SR
    type
    Author
  12. name
    Hui J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Montesinos P
    type
    Author
  2. name
    Recher C
    type
    Author
  3. name
    Vives S
    type
    Author
  4. name
    Zarzycka E
    type
    Author
  5. name
    Wang J
    type
    Author
  6. name
    Bertani G
    type
    Author
  7. name
    Heuser M
    type
    Author
  8. name
    Calado RT
    type
    Author
  9. name
    Schuh AC
    type
    Author
  10. name
    Yeh SP
    type
    Author
  11. name
    Daigle SR
    type
    Author
  12. name
    Hui J
    type
    Author
bibliography ids
  1. nci-bib-06df6828ba40bdc7d69665e2
book metadata
content sha256
8967bd65576c3f6299e36179b63a25b41bbc252b8979ed49f0f3fa1f5108dc49
document type
citation
dois
  1. 10.1056/NEJMoa2117344
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35443108
immutable id
pubmed:35443108@8967bd65576c3f6299e36179b63a25b41bbc252b8979ed49f0f3fa1f5108dc49
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
16
name
The New England journal of medicine
nlm unique id
0255562
pages
1519-1531
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 Jul;19(7):427. doi: 10.1038/s41571-022-00644-y.
    note
    Source null
    related pmid
    35534622
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jun 30;386(26):2535-2536. doi: 10.1056/NEJMc2206489.
    note
    Source null
    related pmid
    35767448
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Jun 30;386(26):2536. doi: 10.1056/NEJMc2206489.
    note
    Source null
    related pmid
    35767449
    relationship
    Comment in
outcomes validated
false
pmid
35443108
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
05956334ae8eabcc5c0d74d5e479e597adbc6ab2d0d8509ec1ddb6bf6acdd4e1
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Apr 21
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35443108/
title
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.

Preserved source evidence · Not medical advice